Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Jan 26, 2021 9:45 AM - Jan 28, 2021 5:00 PM

(US Eastern Standard Time)

Pharmacovigilance and Risk Management Strategies Conference

Session 10: European Regulatory Updates

Session Chair(s)

Sarah  Vaughan

Sarah Vaughan

Head of Vigilance Operations

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

This session will provide updates from the UK’s Medicines & Healthcare products Regulatory Agency, the Danish Medicines Agency and the Netherlands Medicines Evaluation Board. The three speakers will share their current and upcoming work priorities and key challenges for the Regulatory Agencies in pharmacovigilance & risk management for 2021 and beyond.

Learning Objective :
  • Understand the current landscape for pharmacovigilance regulation in Europe.
  • Describe the upcoming work priorities for MHRA, DKMA and MEB in their regulatory roles.
  • Discuss the challenges and opportunities identified for future pharmacovigilance activities in Europe

Speaker(s)

Sarah  Vaughan

Speaker

Sarah Vaughan

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Head of Vigilance Operations

Anja  Van Haren, MSc

Speaker

Anja Van Haren, MSc

Medicines Evaluation Board (MEB), Netherlands

Eudravigilance coordinator

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.